Labcorp LH Stock
Labcorp Price Chart
Labcorp LH Financial and Trading Overview
| Labcorp stock price | 258.59 USD |
| Previous Close | 255.82 USD |
| Open | 254.13 USD |
| Bid | 254.28 USD x 12000 |
| Ask | 254.35 USD x 4000 |
| Day's Range | 253.19 - 256.73 USD |
| 52 Week Range | 241.81 - 293.72 USD |
| Volume | 450.55K USD |
| Avg. Volume | 636.36K USD |
| Market Cap | 20.86B USD |
| Beta (5Y Monthly) | 0.877 |
| PE Ratio (TTM) | 22.555851 |
| EPS (TTM) | 11.3 USD |
| Forward Dividend & Yield | 2.88 (1.12%) |
| Ex-Dividend Date | May 29, 2026 |
| 1y Target Est | 310.12 USD |
LH Valuation Measures
| Enterprise Value | 27.31B USD |
| Trailing P/E | 22.555851 |
| Forward P/E | 13.088232 |
| PEG Ratio (5 yr expected) | 1.08 |
| Price/Sales (ttm) | 1.4750398 |
| Price/Book (mrq) | 2.3989704 |
| Enterprise Value/Revenue | 1.931 |
| Enterprise Value/EBITDA | 12.12 |
Trading Information
Labcorp Stock Price History
| Beta (5Y Monthly) | 0.877 |
| 52-Week Change | -1.99% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 293.72 USD |
| 52 Week Low | 241.81 USD |
| 50-Day Moving Average | 261.16 USD |
| 200-Day Moving Average | 267.48 USD |
LH Share Statistics
| Avg. Volume (3 month) | 636.36K USD |
| Avg. Daily Volume (10-Days) | 605.69K USD |
| Shares Outstanding | 82M |
| Float | 81.59M |
| Short Ratio | 4.75 |
| % Held by Insiders | 0.35% |
| % Held by Institutions | 101.12% |
| Shares Short | 3.43M |
| Short % of Float | 4.19% |
| Short % of Shares Outstanding | 4.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.88 |
| Trailing Annual Dividend Yield | 1.12% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2551 |
| Last Split Factor | 1164:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.65% |
| Operating Margin (ttm) | 10.94% |
| Gross Margin | 28.83% |
| EBITDA Margin | 15.92% |
Management Effectiveness
| Return on Assets (ttm) | 5.31% |
| Return on Equity (ttm) | 11.04% |
Income Statement
| Revenue (ttm) | 14.14B USD |
| Revenue Per Share (ttm) | 170.67 USD |
| Quarterly Revenue Growth (yoy) | 5.80% |
| Gross Profit (ttm) | 4.08B USD |
| EBITDA | 2.25B USD |
| Net Income Avi to Common (ttm) | 941.5M USD |
| Diluted EPS (ttm) | 11.28 |
| Quarterly Earnings Growth (yoy) | 30.50% |
Balance Sheet
| Total Cash (mrq) | 981.1M USD |
| Total Cash Per Share (mrq) | 11.97 USD |
| Total Debt (mrq) | 7.29B USD |
| Total Debt/Equity (mrq) | 83.41 USD |
| Current Ratio (mrq) | 1.726 |
| Book Value Per Share (mrq) | 106.058 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.81B USD |
| Levered Free Cash Flow (ttm) | 1.14B USD |
Profile of Labcorp
| Country | United States |
| State | NC |
| City | Burlington |
| Address | 358 South Main Street |
| ZIP | 27215 |
| Phone | 336 229 1127 |
| Website | https://www.labcorp.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 71000 |
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Q&A For Labcorp Stock
What is a current LH stock price?
Labcorp LH stock price today per share is 258.59 USD.
How to purchase Labcorp stock?
You can buy LH shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Labcorp?
The stock symbol or ticker of Labcorp is LH.
Which industry does the Labcorp company belong to?
The Labcorp industry is Diagnostics & Research.
How many shares does Labcorp have in circulation?
The max supply of Labcorp shares is 82M.
What is Labcorp Price to Earnings Ratio (PE Ratio)?
Labcorp PE Ratio is 22.88407000 now.
What was Labcorp earnings per share over the trailing 12 months (TTM)?
Labcorp EPS is 11.3 USD over the trailing 12 months.
Which sector does the Labcorp company belong to?
The Labcorp sector is Healthcare.
Labcorp LH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX
SPX
US
|
7365.46 USD — |
-1.44
|
3.66B USD — | 7347.6 USD — | 7424.17 USD — | — - | 3.66B USD — |
S&P 500 (Yahoo.com)
GSPC
US
|
7365.46 USD — |
-1.44
|
3.66B USD — | 7347.6 USD — | 7424.17 USD — | — - | 3.66B USD — |
US Tech US Price Setters Index
NQPRCE
US
|
2907.6 USD — |
+0.02
|
— — | 2895.3 USD — | 2916.73 USD — | — - | — — |
The Capital Strength Net Total
NQCAPSTN
US
|
4068.51 USD — |
+0.66
|
— — | 4052.9 USD — | 4077.34 USD — | — - | — — |
US Tech Global BuyBack Achievers
DRBG
US
|
2924.65 USD — |
-0.47
|
— — | 2912.47 USD — | 2934.94 USD — | — - | — — |
NYSE Composite Index
NYA
US
|
23463.63 USD — |
-0.56
|
— — | 23332.58 USD — | 23596.22 USD — | — - | — — |
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
The Capital Strength Index
NQCAPST
US
|
3405.85 USD — |
+0.65
|
— — | 3392.81 USD — | 3413.24 USD — | — - | — — |
US Tech US BuyBack Achievers Sel
DRBS
US
|
2340.09 USD — |
+0.42
|
— — | 2336.31 USD — | 2349.71 USD — | — - | — — |
- {{ link.label }} {{link}}


